1. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness

   • Yan Zhang
   • Mei-Yu Hu
   • Kang-Da Liu

   Original Paper 20 June 2006 Pages: 685 - 697

   

2. Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma

   • G. Treiber
   • T. Wex
   • P. Malfertheiner

   Original Paper 12 July 2006 Pages: 699 - 708

   

3. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma

   • Hui Zhang
   • Qing-Hai Ye
   • Lun-Xiu Qin

   Original Paper 20 June 2006 Pages: 709 - 717

   

4. Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib

   • Shigenori Kanazawa
   • Kazuyuki Yamaguchi
   • Shosaku Nomura

   Original Paper 12 July 2006 Pages: 719 - 725

   

5. Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer

   • Andrei Anghel
   • Marius Raica
   • Oana Mitrasca

   Original Paper 22 June 2006 Pages: 727 - 733

6. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa

   • Keizo Kato
   • Akira Hara
   • Toshiyuki Shibata

   Original Paper 22 June 2006 Pages: 735 - 743

   

7. Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy

   • Thomas J. Vogl
   • Wolfram Schwarz
   • Matthias Heller

   Original Paper 21 July 2006 Pages: 745 - 755